Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.
Zag Bio is a biotechnology company that designs thymus-targeting bifunctional antibody medicines to treat and prevent autoimmune diseases.
Electra Therapeutics is a clinical-stage biotechnology company developing antibody therapies for immunological diseases and cancer.
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
Character Bio is a platform that merges genomics with clinical data and AI technology, focusing on patients affected by AMD.
Kasha delivers pharmaceutical products and household goods to low-income consumers, resellers, pharmacies, and health facilities.
Eligobiotics provides a new approach to explore, understand, and control bacterial ecosystems both in human and animals.
Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes.
Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.
Glycomine is an early-stage biotech working on replacement therapies for rare diseases.
Attovia Therapeutics is a biologics platform specializing in biotherapeutics for immune-mediated diseases.
Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.
Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.
Aetion provides real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers.
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
Resalis Therapeutics sviluppa un farmaco in grado di inibire un micro-RNA per il trattamento di alcune malattie metaboliche
Agomab is a biotechnology company developing therapies that maintains and restores organ function in diseases characterized by fibrosis.
EuroAPI develops, manufactures and supplies the active-ingredient solutions for healthcare.
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.
Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.
Graviton develops novel therapeutics for the treatment of autoimmune, cancer, certain genetic, fibrotic, and other serious diseases.
Biotechnology, clinical stage, CNC, autoimmune, fibrotic indications
Sanofi has invested in 127 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sanofi's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Life Science. The firm invests across 22 different industry categories.
Among tracked funding rounds, EuroAPI received $825.5M in a Post-IPO Debt round. Sanofi's total known invested capital is $6.2B.
Sanofi's average investment size is $103.0M across its portfolio of 127 companies.
Recent Sanofi portfolio additions include T-Therapeutics, Zag Bio, Electra Therapeutics, ReCode Therapeutics, Character Biosciences. These companies were founded in 2020 or later.